Cathay Biotech Inc. (SHA: 688065)
China flag China · Delayed Price · Currency is CNY
51.73
-0.28 (-0.54%)
Nov 13, 2024, 3:00 PM CST

Cathay Biotech Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Operating Revenue
2,7172,0672,3322,2961,4881,779
Upgrade
Other Revenue
47.1747.17108.6767.679.49137.3
Upgrade
Revenue
2,7642,1142,4412,3631,4971,916
Upgrade
Revenue Growth (YoY)
27.43%-13.39%3.28%57.86%-21.87%9.05%
Upgrade
Cost of Revenue
1,9171,5351,6121,526808.771,065
Upgrade
Gross Profit
846.65579.23829.2837.21688.42851.14
Upgrade
Selling, General & Admin
235.38221.61232.28175.11143.25214.11
Upgrade
Research & Development
231.51189.13187.71133.5384.390.16
Upgrade
Other Operating Expenses
61.019.21-4.0922.9410.4517.61
Upgrade
Operating Expenses
530.63413.68422.59337.95241.23320.18
Upgrade
Operating Income
316.02165.55406.61499.25447.19530.96
Upgrade
Interest Expense
-31.32-32.17-20.01-16.29-3.86-17.03
Upgrade
Interest & Investment Income
165.3219.77236.78229.6152.1815.52
Upgrade
Earnings From Equity Investments
-6.86-7.82-3.71---
Upgrade
Currency Exchange Gain (Loss)
29.5929.5982.97-14.14-18.268.03
Upgrade
Other Non Operating Income (Expenses)
-82.86-5.7-4.61-0.59-0.327.86
Upgrade
EBT Excluding Unusual Items
389.87369.22698.03697.84476.93545.33
Upgrade
Gain (Loss) on Sale of Investments
----9.158.05
Upgrade
Gain (Loss) on Sale of Assets
-0.01-0.010.07---2.47
Upgrade
Asset Writedown
-24.13-0.26-0.02-0.06-1.15-
Upgrade
Other Unusual Items
78.2579.97-2.0926.6635.854.96
Upgrade
Pretax Income
443.98448.92695.99724.45520.79555.87
Upgrade
Income Tax Expense
50.3540.3983.3490.9463.4576.99
Upgrade
Earnings From Continuing Operations
393.63408.54612.65633.51457.34478.88
Upgrade
Minority Interest in Earnings
4.19-42.01-59.39-38.790.33-
Upgrade
Net Income
397.82366.52553.27594.72457.67478.88
Upgrade
Net Income to Common
397.82366.52553.27594.72457.67478.88
Upgrade
Net Income Growth
4.42%-33.75%-6.97%29.94%-4.43%2.70%
Upgrade
Shares Outstanding (Basic)
585582582583543508
Upgrade
Shares Outstanding (Diluted)
585582582583543508
Upgrade
Shares Change (YoY)
0.97%-0.10%-0.12%7.38%6.91%1.57%
Upgrade
EPS (Basic)
0.680.630.951.020.840.94
Upgrade
EPS (Diluted)
0.680.630.951.020.840.94
Upgrade
EPS Growth
3.42%-33.68%-6.86%21.01%-10.61%1.11%
Upgrade
Free Cash Flow
-157.41-1,000-3,395-880.49-248.15-151.52
Upgrade
Free Cash Flow Per Share
-0.27-1.72-5.83-1.51-0.46-0.30
Upgrade
Dividend Per Share
0.1900.1900.1800.3210.571-
Upgrade
Dividend Growth
5.56%5.56%-44.00%-43.75%--
Upgrade
Gross Margin
30.63%27.40%33.97%35.42%45.98%44.42%
Upgrade
Operating Margin
11.43%7.83%16.66%21.12%29.87%27.71%
Upgrade
Profit Margin
14.39%17.34%22.66%25.16%30.57%24.99%
Upgrade
Free Cash Flow Margin
-5.70%-47.32%-139.06%-37.25%-16.57%-7.91%
Upgrade
EBITDA
608.83446.49671.73667.79565.51647.24
Upgrade
EBITDA Margin
22.03%21.12%27.52%28.25%37.77%33.78%
Upgrade
D&A For EBITDA
292.81280.95265.12168.54118.32116.27
Upgrade
EBIT
316.02165.55406.61499.25447.19530.96
Upgrade
EBIT Margin
11.43%7.83%16.66%21.12%29.87%27.71%
Upgrade
Effective Tax Rate
11.34%9.00%11.97%12.55%12.18%13.85%
Upgrade
Revenue as Reported
2,7642,1142,4412,3631,4971,916
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.